INTRODUCTION
============

The Leucine-responsive regulatory protein (Lrp) family of transcriptional regulators is one of the largest families of bacterial/archaeal regulators ([@gkt021-B1; @gkt021-B2; @gkt021-B3]). Lrp-like regulators exhibit a similar architecture ([@gkt021-B4; @gkt021-B5; @gkt021-B6; @gkt021-B7; @gkt021-B8; @gkt021-B9]). The N-terminal DNA-binding domain bears a winged helix-turn-helix motif; the C-terminal *R*egulation of *A*mino acid *M*etabolism (RAM) domain shows a characteristic αβ sandwich fold (βαββαβ) ([@gkt021-B5]) and is involved in effector-binding and oligomerization. Intriguingly, despite these structural similarities, bacterial and archaeal Lrp-like regulators modulate activity of two different transcription machineries. Bacterial Lrp-like regulators modulate the initiation frequency of a unique RNA polymerase that directly binds core promoter elements ([@gkt021-B10]). In contrast, archaeal members regulate the activity of a eukaryotic-like transcription apparatus that consists of a TATA box, transcription factor B responsive element (BRE) and initiator (Inr); three general transcription factors \[TATA binding protein (TBP), transcription factor B and transcription factor E\] and a complex RNA polymerase that is most homologous to eukaryotic RNA polymerase II ([@gkt021-B11; @gkt021-B12; @gkt021-B13]). As in eukarya, the unique archaeal RNA polymerase is recruited by protein--protein interactions with transcription factors. The fundamental differences between the bacterial and archaeal transcriptional machinery appeal for a different mode of action of bacterial and archaeal Lrp-like regulators, in particular concerning transcriptional activation.

*Escherichia coli* Lrp, archetype of the Lrp-like family, is a global regulator that directly or indirectly affects a plenitude of metabolic pathways ([@gkt021-B14; @gkt021-B15; @gkt021-B16]) and was recently shown to use several amino acids as cofactors ([@gkt021-B17]). This regulator is proposed to play an important role in coordination of the metabolic switch of microorganisms on transitions between regimes of feast and famine ([@gkt021-B18],[@gkt021-B19]). In contrast, most other bacterial Lrp-like regulators act more specific, with one or a few targets only, and are generally involved in control of amino acid metabolism. Much less is known about archaeal members. Frequently, their cofactor has not yet been identified, targets apart from the control region of their own gene (autoregulation) are rarely known and molecular mechanisms of regulatory process have not been unravelled \[for a review see ([@gkt021-B2])\]. Nevertheless, a few case studies, in particular with regulators from model organisms *Sulfolobus solfataricus* (crenarchaeote) and *Methanocaldococcus jannaschii* (euryarchaeote), indicate that archaeal Lrp-like regulators appear to be more versatile than their bacterial counterparts and that they are also involved in regulation of central metabolism ([@gkt021-B20],[@gkt021-B21]).

LysM is an Lrp-like regulator from hyperthermoacidopilic crenarchaeon *S. solfataricus* that was previously shown to bind the *lysWXJK* control region and was proposed to act as a lysine-sensitive co-activator ([@gkt021-B22]). Both LysM and its target sequence in the *lysW* operator are highly conserved among *Sulfolobus* genomes. However, a high-resolution contact map of LysM--operator DNA contacts has not been established, DNA sequence specificity of LysM has not been thoroughly studied and, besides *lysW*, no additional target genes have been identified to date.

To gain further insights into LysM action and its physiological role, we established a high-resolution contact map of LysM--*lysW* promoter/operator interactions and performed a saturation mutagenesis of the symmetrical LysM consensus box. Furthermore, we identified additional LysM-binding sites in the genome of *S. solfataricus* and validated these data with *in vitro* DNA-binding assays for a subset of selected targets. The data presented here clearly demonstrate that LysM binds with high affinity to several additional binding sites in the *Sulfolobus* genome both *in vivo* and *in vitro.* Furthermore, we show that LysM has a rather broad ligand-binding specificity and that several amino acids besides [l]{.smallcaps}-lysine significantly affect its DNA-binding capacity.

MATERIALS AND METHODS
=====================

Strains and growth conditions
-----------------------------

*E. coli* strain DH5α was used for all cloning and plasmid propagation purposes. *E. coli* BL21(DE3) was used as a host for overexpression of recombinant proteins. *S. solfataricus* P2 (DSM1617) and *Sulfolobus acidocaldarius* (DSM639) were grown aerobically at 80°C and 75°C, respectively, in Brock basic medium ([@gkt021-B23]) supplemented with 0.2% sucrose, with or without [l]{.smallcaps}-lysine (5 mM), as indicated.

DNA and RNA extractions
-----------------------

Genomic DNA (gDNA) from *S. solfataricus* P2 and *S. acidocaldarius* was extracted from 4 ml of a culture with a QuickPick SML gDNA kit (BioNobile). Plasmid DNA was extracted from transformed *E. coli* DH5α with a Miniprep kit (Qiagen). For RNA extraction, 1 ml of an exponentially grown *S. solfataricus* P2 culture \[optical density (OD~600\ nm~) of 0.3\] was mixed with 2 ml RNAprotect Bacteria Reagent (Qiagen) and centrifuged. Pelleted cells were subsequently lysed with proteinase K (Qiagen), and RNA was extracted with an RNeasy mini kit (Qiagen). RNA samples were mixed with 10 U of DNase I (Roche) and incubated for 20 min at 37°C to remove any contaminating gDNA. DNase I was removed with the RNeasy mini kit according to the clean-up procedure. All samples were analysed by end-point polymerase chain reaction (PCR) with primers DC1115f and DC1116r ([Supplementary Table S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)) to confirm absence of gDNA.

Plasmid constructions and DNA manipulations
-------------------------------------------

To construct plasmid pET24*lysM~Sa~-6xhis* for overexpression of C-terminal 6xHis-tagged *S. acidocaldarius* LysM (LysM~Sa~), the open reading frame (ORF) region of Saci_0752 was PCR-amplified using gDNA as template and primers DC689f and DC690r. The amplicon was digested with NdeI and XhoI and ligated into kanamycin-resistant expression vector pET24a (Novagen) digested with the same enzymes. Vector pBendLYSM for the circular permutation assay was obtained by ligating the annealed oligonucleotides DC826f and DC827r bearing sticky XbaI sites into pBend2 ([@gkt021-B24]) digested with the same enzyme. All constructs were verified by DNA sequencing. All oligonucleotides used in this work are listed in the [Supplementary Data](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1) ([Supplementary Table S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)).

Production and purification of recombinant LysM from *S. solfataricus* and *S. acidocaldarius*
----------------------------------------------------------------------------------------------

Untagged recombinant *S. solfataricus* LysM (LysM~Ss~) was produced in *E. coli* BL21(DE3) cells transformed with plasmid pLUW632 ([@gkt021-B22]). Induction was with 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside at a cell density of 9 × 10^8^ml^−1^, followed by overnight growth at 25°C. LysM~Ss~ was purified as described ([@gkt021-B25]) with two modifications: after harvesting by centrifugation, cells were sonicated for 15 min at 20% of maximal amplitude in a VibraCell® sonicator equipped with a continuously cooled cell; purified protein was dialyzed overnight at 4°C against LysM storage buffer composed of 20 mM Tris (pH 8.0) and 20% glycerol.

We purified recombinant C-terminal 6xHis-tagged LysM from *S. acidocaldarius* (LysM~Sa~) from *E. coli* BL21(DE3) cells containing plasmid pET24-*lysM~Sa~-6xhis*. LysM~Sa~ overexpression was induced by adding 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside at a cell density of 9 × 10^8^ml^−1^, followed by overnight growth at 30°C. Cells were collected by centrifugation, resuspended in 6 ml of binding buffer (20 mM phosphate buffer, 0.5 M NaCl and 40 mM imidazole, pH 7.4) and followed by sonication and centrifugation (10 min at 7000 rpm in a Jouan centrifuge with AB50.10 A rotor). Soluble extract was heated at 80°C during 10 min and subsequently centrifuged to remove denatured proteins. Harvested supernatant was loaded on a HisTrap^TM^ FF 1 ml column (GE Healthcare) operated by an AKTA^TM^ fast protein liquid chromatography system (GE Healthcare). The column was extensively equilibrated with binding buffer before application of a linear gradient with elution buffer (binding buffer with 500 mM instead of 40 mM imidazole). Peak fractions were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and electrophoretic mobility shift assay (EMSA), and then collected and dialyzed against LysM storage buffer before storage at −80°C. In contrast to N-terminally His-tagged LysM~Ss~ ([@gkt021-B22]), purified C-terminally His-tagged LysM~Sa~ did not precipitate and was correctly folded, as indicated by DNA-binding activity and cofactor response. All LysM~Ss~ and LysM~Sa~ protein concentrations are expressed in monomer equivalents.

*In vitro* DNA binding: EMSAs, in-gel OP--Cu footprinting and pre-modification binding interference analyses
------------------------------------------------------------------------------------------------------------

EMSAs were performed as described ([@gkt021-B26]), either with gel-purified single 5′-end ^32^P-labelled PCR fragments or with purified 47-bp duplexes generated by annealing of complementary oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)), of which one was 5′-end labelled with \[γ-^32^P\]-ATP by T4 polynucleotide kinase. Unless otherwise stated, separation of free DNA from DNA--protein complexes was performed on 6 and 8% polyacrylamide gels for the PCR fragments and 47-bp duplexes, respectively. LysM-binding reactions were performed in LrpB binding buffer as described previously ([@gkt021-B27]) with 25 µg ml^−1^ sonicated herring sperm DNA as non-specific competitor.

EMSA autoradiographs were scanned with a Microtek Bio-5000 scanner, and binding equilibrium association constants (K~A~s) were determined with the Densitometric Image Analysis Software, for which a description will be published elsewhere. To enable comparison of K~A~s measured at different times, relative K~A~s were determined by normalization with the K~A~ for binding to the consensus sequence fragment, measured each time in parallel. In-gel footprinting of separated LysM--DNA complexes with the 1,10-phenanthroline-copper \[(OP)~2~-Cu^+^\] ion (Cu--OP) was performed as described ([@gkt021-B28]). Missing contact and pre-methylation binding interference experiments were performed as described previously ([@gkt021-B29]), using LrpB binding buffer to perform binding reactions. Reference ladders were generated by chemical sequencing methods ([@gkt021-B30]).

DNA bending test
----------------

Circular permutation assay ([@gkt021-B24],[@gkt021-B31]) was performed with a set of six fragments of identical length (156 bp) bearing the 15-bp consensus LysM binding site at various distances from the extremities. Fragments were generated by PCR amplification with pBendLYSM plasmid DNA as template and oligonucleotide pairs DC826f-EP31r (fragment I), EP15-EP16r (fragment II), EP17-EP18r (fragment III), EP9-EP10r (fragment IV), EP19-EP20r (fragment V) and EP21-EP22r (fragment VI) as primers. The LysM binding site is located closest to an extremity on fragments I and VI, and approximately in the middle in fragment IV. The apparent bending angle was calculated from relative mobilities of complexes on 8% polyacrylamide, as described ([@gkt021-B31]).

Real-time quantitative PCR
--------------------------

First-strand cDNA was synthesized from 30 ng RNA with SuperScript® III First-Strand Synthesis SuperMix kit (Invitrogen), according to the manufacturer's instructions. Quantitative real-time PCR (qPCR) was carried out in a Bio-Rad iCycler with iQ™ SYBR® Green Supermix (Bio-Rad) using following amplification protocol: initial denaturation at 95°C for 3 min followed by 40 cycles of 95°C for 10 s and 55°C for 30 s, and one cycle of 95°C for 1 min and 55°C for 1 min. Reactions were performed with 12.5 µl SYBR Green supermix and 20-fold diluted cDNA in a total volume of 25 µl. Amplification reactions were performed in technical duplicates on biological quadruplicates, with a reaction without template as negative control. Specificity was verified by melt curve analysis. Sso0951, encoding TBP, was used as a reference gene for normalization. Of four genes that were tested (TBP, mini chromosome maintenance, 23 S rRNA and RNAP subunit B), TBP proved to have the most stable expression in tested conditions. Quantification cycles (C~q~s) were determined with Bio-Rad iQ5 software. Efficiencies of gene-specific primer pairs were calculated by determining the slope of a linear regression curve resulting from C~q~ values for a 10-fold dilution series with gDNA as a template. Relative expression ratios were calculated by integrating knowledge of primer pair efficiencies ([@gkt021-B32]).

Generation of LysM-specific nanobodies
--------------------------------------

LysM-specific nanobodies were generated by immunizing an alpaca (*Vicugna pacos*) with purified full-length 6xHis-tagged LysM~Sa~. A total of six injections at weekly intervals were given, each with 200 µg protein. Plasma obtained 4 days after the last injection showed an end titre of ∼10^4^. Subsequently, using peripheral blood lymphocytes, a variable domain of heavy chain antibodies library was constructed as described ([@gkt021-B33]). The LysM~Sa~-directed nanobodies were generated according to the previously described bio-panning procedure ([@gkt021-B33]). A chromatin immunoprecipitation (ChIP)-grade nanobody that does not disrupt LysM~Sa~- and LysM~Ss~-containing protein--DNA complexes was selected by enzyme-linked immunosorbent assay and EMSA (data not shown).The specificity of the nanobody for LysM was further tested in pull-down assays ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)).

ChIP-chip
---------

ChIP was performed according to ([@gkt021-B34]). *S. solfataricus* P2 (DSM1617) cells were harvested at mid-exponential growth phase (OD~600nm~ ∼0.6). Two biological replicates were used for each growth condition (with 5 mM lysine and without lysine). For enrichment analysis, qPCR was performed, as described previously, with 5 ng DNA as template. The 2^-\[Delta\]\[Delta\]Cq^ method was applied to calculate ChIP enrichment from the ChIP DNA as compared with input DNA ([@gkt021-B35]). The *lysW* operator region was amplified with primers DC1102f and DC1103r and for normalization, a reference sequence in *E. coli* DNA that was spiked into all samples was amplified with the primers DC821 and DC822 ([Supplementary Table S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). The DNA tiling microarray was designed and manufactured by NimbleGen (Roche) and sample labelling, hybridization and array processing were executed at NimbleGen, with ChIP input and output samples labelled with Cy3 and Cy5, respectively.

Micro-array data analysis was performed using an extended version of the programme described by ([@gkt021-B36]), which uses the Ringo package of R-Bioconductor ([@gkt021-B37]).The source code of the extended programme is made available through <http://micr.vub.ac.be>. It includes importing data, data quality assessment, pre-processing of data, identifying ChIP-enriched regions (chers) and determining significant differences between experiments with and without lysine. To avoid detection of peaks in the log~2~ ratios due to reduced signal-to-noise ratios at low-intensity probes, as part of the pre-processing step, average log~2~ intensities over red and green channels are calculated for each probe, and probes with resulting values smaller than the average minus twice the standard deviation are replaced by missing values. Next, a standard normalization step is performed in which Tukey's biweight mean across each sample's log~2~ ratios is subtracted from individual log~2~ ratios, and resulting values are averaged over replicates and smoothed over a 100-bp window to reduce stochastic noise and systematic noise due to differences in hybridization efficiency of different probes.

A region was considered as ChIP-enriched if smoothed log~2~ ratios of all reporters mapped to this region exceed a threshold of 2 and if the region contains at least five probe-matched positions, each of these positions being \<500 bp apart from another matched position within this region. A constant threshold of 2 was chosen rather than the more statistically inspired version used by ([@gkt021-B36]) to maintain an almost constant number of detected chers across biological replicates, rather than ensuring that the number of detected false-positives is smaller than a certain amount. The resulting chers were extended at both sides with 150 bp, and overlapping chers were then combined into one cher. This additional step was necessary to make sure that a cher is only detected once: sometimes a cher could be detected more than once due to, for example, a single reporter level that is under the threshold, whereas a series of neighbouring reporter levels are above the threshold.

Only chers that were present in both biological replicates for at least one of the experiments with and without lysine were taken into account for further analysis. To determine which chers detected in presence of lysine were significantly enhanced compared with the situation without lysine and vice versa, the same procedure to detect chers was repeated with a threshold of 1, and significantly differentially enhanced chers were defined as those that exceeded the threshold of 2 for one set of biological replicates and did not exceed the threshold of 1 for the other set.

*In silico* binding site prediction
-----------------------------------

A binding energy-weighted sequence logo for LysM DNA-binding sequence specificity has been calculated according to ([@gkt021-B38]) by equating the frequency of each base to the relative K~A~for binding to a consensus variant fragment having the corresponding substitution divided by the sum of the four K~A~values for each of four bases at this position.

For each cher sequence, the best potential binding site was predicted based on the energy-based position weight matrix, and the corresponding theoretical K~A~ was calculated. This is shown in [Table 1](#gkt021-T1){ref-type="table"} and [Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1). Table 1.Predicted binding affinities for potential/confirmed LysM-binding motifs in selected targets that were further studied by *in vitro* DNA-binding assaysPredicted K~D~ (nM)Closest ORFPredicted binding motifObserved *in vitro* binding0.3Sso2043**G**TA**CG**ATTAG**CG**TA**C**++1.7Sso0977**G**TT**CG**TATGT**CG**AA**C**++6Sso1906**G**TA**CG**ATTACA**G**TAT+9Sso0157**G**TT**C**TAAAAT**CG**TA**C**++11Sso0684**G**TT**CG**GAAAT**C**AAA**C**++42Sso2336ATA**CG**CTAGG**C**TTA**C**+54Sso0572CTT**CG**ATACA**CG**AAT+78Sso0155ATA**CG**GGCGGA**G**AAT−103Sso2824**G**CA**CG**CTATTA**G**AGT−158Sso2497**G**TG**CG**ATTTCA**G**CGT+172Sso0340CGG**CG**GGATT**CG**AA**C**−[^1]

RESULTS
=======

The LysM--*lysW* operator interaction in *S. solfataricus* and *S. acidocaldarius*
----------------------------------------------------------------------------------

LysM is highly conserved among all sequenced *Sulfolobus* species, and their lysine biosynthesis genes are invariably organized in two consecutive operons with the same polarity, *lysYZM* and *lysWXJK* ([Figure 1](#gkt021-F1){ref-type="fig"}A). In *S. solfataricus*, only the latter bears a target site for LysM ([@gkt021-B22]). To analyse functional conservation of LysM and its target site(s), we performed EMSAs of LysM~Ss~ and its orthologue LysM~Sa~ from *S. acidocaldarius* binding to the *lysW* operator of both organisms ([Figure 1](#gkt021-F1){ref-type="fig"}B and C). The results indicate that each regulator binds the two operators with a similar binding affinity. However, binding and migration patterns showed remarkable differences. LysM~Ss~ formed two distinct complexes (B1 and B2) with the cognate *lysW* operator in a concentration-dependent manner, and some supershifted smear at the highest concentration used. In contrast, binding of LysM~Ss~ to the heterologous *lysW* operator from *S. acidocaldarius* resulted in the formation of essentially one major complex (B1) and of a small amount of a second, slower migrating complex (B2). At the highest protein concentrations, two additional complexes (B3 and B4) were formed that exhibit an even lower relative mobility. Binding of LysM~Sa~ to both *lysW* operators appeared very similar and produced essentially one major complex (B1), a tiny amount of a slower migrating complex (B2) and, at the highest protein concentrations, supershifted smear. Figure 1.Functional conservation of the LysM--*lysW* operator interaction in *Sulfolobus*. (**A**) Schematic overview of genomic organization of the *lys* locus. ORFs are depicted by arrows, with names of corresponding genes mentioned above. Transcription start sites are indicated with small black arrows. The genomic organization shown here is identical for all sequenced *Sulfolobus* species, and amino acid sequence identity between *S. solfataricus* and *S. acidocaldarius* orthologues is mentioned below each *lys* gene. The *lysW* promoter/operator region that is subject of the interaction analysis is indicated by a rectangle. (**B**) EMSAs of binding of LysM~Ss~ to the *lysW* control regions of *S. solfataricus* (on a 203-bp fragment) and *S. acidocaldarius* (on a 188 bp-fragment), as indicated. Protein concentrations are mentioned on top of the autoradiograph. Positions of free DNA (F), free single-stranded DNA (SS) and protein--DNA complexes (B1--B4) are pointed out. (**C**) EMSAs of binding of LysM~Sa~ to the *lysW* control regions of *S. solfataricus* and *S. acidocaldarius*, as indicated. Notations are the same as in subpanel (B).

Previously, a single high-affinity binding site for LysM~Ss~ was identified by DNase I footprinting at low protein concentrations, whereas higher concentrations resulted in protection of a large, but undefined, zone and in the appearance of hyper-reactive bands ([@gkt021-B22]). In-gel footprinting with the Cu--OP ion ([Figure 2](#gkt021-F2){ref-type="fig"}A and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)) demonstrated that in complex B1, LysM~Ss~ protected a stretch of 16 and 15 nucleotides (nt) on the top and bottom strands, respectively ([Figure 2](#gkt021-F2){ref-type="fig"}F). This zone extends from position −59 to −74 upstream of the initiation codon (−50 to −65 upstream of the transcription start site) and corresponds to the upstream binding site in [Figure 2](#gkt021-F2){ref-type="fig"}F. The slower migrating complex B2 showed two distinct zones of protection, one identical to that observed in complex B1, and an additional slightly shorter stretch of 14 nt on the top strand and of 11 nt on the bottom strand ([Figure 2](#gkt021-F2){ref-type="fig"}A and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). This second zone of LysM binding (−31 to −44) is located slightly downstream of the major LysM binding site and covers the BRE and part of the TATA box of the *lysW* promoter ([Figure 2](#gkt021-F2){ref-type="fig"}F).The centres of the principal high-affinity site and of the more degenerated accessory site are 21 bp apart; consequently, equivalent positions in both sites are aligned on the same face of the helix. Figure 2.High-resolution contact probing of the LysM---ysW operator interaction. (**A**) In-gel Cu--OP footprinting experiment of binding of LysM~Ss~ to the *lysW* operator region of *S. solfataricus* (203-bp fragment, top strand labelled). On top, the EMSA is shown with indication of used protein concentrations (in nM) and populations of free (F) and bound (B1--B2) DNA that were further analysed by denaturing acrylamide gel electrophoresis, of which the autoradiograph is shown below. C + T and A + G indicate Maxam--Gilbert sequencing ladders. The region that is protected in both nucleoprotein populations B1 and B2 is indicated with a black bar; the region that is only protected in complex B2 is indicated with a grey bar. (**B**) In-gel Cu--OP footprinting experiment of binding of LysM~Sa~ to the *lysW* operator region of *S. acidocaldarius* (188-bp fragment, top strand labelled). Notations are the same as in subpanel (A). (**C**) Depyrimidation binding interference experiment of binding of LysM~Sa~ to the *lysW* operator region of *S. acidocaldarius*. Populations of input (I), free (F1 and F2) and bound DNA (B1, B2 and B3) are indicated. Observed effects are pointed out with horizontal lines with the corresponding nucleotides mentioned. (**D**) Depurination binding interference experiment of binding of LysM~Sa~ to the *lysW* operator region of *S. acidocaldarius*. (**E**) Pre-methylation binding interference experiment of binding of LysM~Sa~ to the *lysW* operator region of *S. acidocaldarius.* (**F**) Alignment of the nucleotide sequence of the *lysW* operator region of *S. acidocaldarius* and *S. solfataricus* with a summary of all results of footprinting and binding interference experiments. The *lysM* translational stop codon is underlined, the *lysW* translational initiation codon is in bold and the semi-palindromic LysM binding motif is boxed, as are the BRE and TATA box promoter elements \[predicted based on transcription start site determination in ([@gkt021-B22])\]. An asterisk indicates the transcription initiation site. Positions are numbered with respect to the *lysW* initiation codon of *S. acidocaldarius*. Protection against chemical cleavage in Cu--OP footprinting is indicated with a grey shaded region. On top of the sequence, a helical representation demonstrates minor and major groove orientation of LysM~Sa~ binding. Strand regions that were protected against cleavage are grey coloured, while binding interference effects are depicted by following symbols: circles = depurination binding interference; squares = depyrimidation binding interference; triangles = pre-methylation binding interference. Open symbols represent weak effects; filled symbols strong effects. Subpanels (A--E) show representative experiments that were performed with DNA having the top strand labelled; experiments were similarly performed with DNA having the bottom strand labelled, as summarized here and shown in [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1).

The major complex B1 formed on binding of LysM~Sa~ to the *lysW* operator of *S. acidocaldarius* showed a continuous stretch of protection of 18 nt on the top strand and 16 nt on the bottom strand ([Figure 2](#gkt021-F2){ref-type="fig"}B and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). This zone extends from position −55 to −72 upstream of the initiation codon and aligns perfectly with the principal LysM binding site in the *lysW* operator of *S. solfataricus* ([Figure 2](#gkt021-F2){ref-type="fig"}F). Complex B2 did not show an additional clear zone of protection. Formation of this minor complex might therefore be due to binding of a higher oligomeric state of LysM~Sa~ (without further contact with the DNA), to establishment of additional non-specific interactions, or to formation of 'sandwich-type' structures.

High-resolution contact mapping of the LysM--*lysW* operator interaction in *S. acidocaldarius*
-----------------------------------------------------------------------------------------------

Missing contact probing assays ([@gkt021-B39]) performed at different protein concentrations ([Figure 2](#gkt021-F2){ref-type="fig"}C and F and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)) indicated that removal of five pyrimidines of the top strand (T-70, C-68, T-63, T-62 and C-61) and seven of the bottom strand (C-72′, C-71′, T-66′, T-65′, C-60′, T-59′ and T-58′) strongly inhibits complex formation with LysM~Sa~. Similarly, removal of eight purines of the top strand (G-72, G-71, A-69, A-66, A-65, G-60, A-59 and A-58) and six of the bottom strand (A-70′, G-68′, A-64′, A-63′, A-62′ and G-57′) strongly interferes with complex formation ([Figure 2](#gkt021-F2){ref-type="fig"}D and F and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Pre-methylation binding interference experiments demonstrated that methylation of three guanine residues of the top strand (G-72, G-71 and G-60) and three of the bottom strand (G-68′, G-57′ and G-56′) strongly reduces binding of LysM~Sa~ ([Figure 2](#gkt021-F2){ref-type="fig"}E and F and [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Removal of any of these six guanine residues also strongly inhibited LysM~Sa~ binding, except G-56′. As this position was not protected in the Cu--OP footprinting assay, we may conclude that G-56′ is not directly contacted and that the negative effect of pre-methylation of this base most likely results from steric hindrance exerted by the methyl group on contact of LysM~Sa~ with an adjacent base-specific or backbone group. These results confirm recognition of a semi-palindromic sequence centred around position −64, which is highly conserved between *S. solfataricus* and *S. acidocaldarius* ([@gkt021-B22]) ([Figure 2](#gkt021-F2){ref-type="fig"}F). The binding site overlaps part of the *lysM* ORF and its translational stop codon. Furthermore, it is located 11 bp upstream of the predicted *lysW* BRE and TATA box. Dimethyl sulphate methylates guanine residues at position N^7^ in the major groove. Therefore, we may conclude that LysM interacts specifically with two consecutive major groove segments and intervening minor groove of the operator, all aligned on one face of the DNA helix ([Figure 2](#gkt021-F2){ref-type="fig"}F). It is interesting to note that in this helical orientation, TBP and LysM are expected to bind to the same face of the DNA.

Sequence specificity of LysM binding
------------------------------------

Based on phylogenetic footprinting of the *lysW* operator region, a degenerate consensus sequence was derived that allowed the definition of a strictly palindromic 15-bp consensus sequence for LysM binding ([Figure 3](#gkt021-F3){ref-type="fig"}A). LysM~Sa~ specifically binds a 47-bp DNA fragment harbouring this consensus sequence and forms a single complex in EMSA ([Figure 3](#gkt021-F3){ref-type="fig"}B). The average equilibrium association constant (K~A~) for this interaction was calculated to be 196 μM^−1^ (corresponding dissociation constant K~D~ = 5 nM). Figure 3.Binding and LysM~Sa~-induced DNA bending of the consensus binding site. (**A**) Cartoon representing the LysM consensus sequence. Inverted repeat elements are indicated with arrows; the axis of 2-fold symmetry is depicted by an ellipse. (**B**) EMSA of binding of LysM~Sa~ to a DNA fragment encompassing the consensus sequence. This fragment was generated by hybridization of 47-nt-long complementary oligonucleotides containing the 15-nt LysM box flanked on either side by the 16-nt stretches that surround the LysM~Sa~ binding site of the *lysW* operator in the *S. acidocaldarius* genome. Positions of bound (B) and free (F) DNA are indicated, as are applied LysM~Sa~ concentrations (in nM). (**C**) EMSA with permuted DNA fragments bearing the consensus binding site. In all binding reactions, we added 30 nM LysM~Sa~. Characteristics of fragments are further described in Materials and Methods, and lane numbers in the EMSA correspond to fragment numbers. Positions of bound (B) and free (F) DNA are indicated. (**D**) Graphical representation of the relative mobility (μ) of different complexes as a function of the position of the insert sequence within the DNA fragment. The apparent bending angle (α) was calculated as follows: μM/μE = cos (α/2) (M = insert in the centre of the fragment, resulting in the lowest value of μ, and E = insert at the end of the fragment).

Six fragments of identical length but with the LysM consensus site permuted were used to analyse DNA bending ([Figure 3](#gkt021-F3){ref-type="fig"}C and D). All six fragments migrated with a similar mobility when being unbound, indicating the absence of a measurable intrinsic curvature ([Figure 3](#gkt021-F3){ref-type="fig"}C). Therefore, the role of structure specificity in LysM binding is limited. In contrast, LysM~Sa~--DNA complexes displayed clear differences in relative mobilities, which allowed calculation of an average apparent bending angle of 36° ([Figure 3](#gkt021-F3){ref-type="fig"}C and D). This result contrasts the lack of measurable DNA bending reported for LysM~Ss~ using a similar assay ([@gkt021-B22]).

To determine the sequence specificity of LysM binding, EMSAs with LysM~Sa~ binding to a set of 22 mutated variants (all possible single-bp substitutions at all positions of one half-site) were performed ([Figure 4](#gkt021-F4){ref-type="fig"}A), and relative K~A~s were calculated ([Supplementary Table S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Due to full symmetry of the consensus site, only one substitution was analysed at position 0. This analysis resulted in a quantitative model of binding specificity, representing a significant part of the complete binding energy landscape. This model is graphically represented by an energy-normalized sequence logo ([Figure 4](#gkt021-F4){ref-type="fig"}B). The total information content of the LysM binding specificity is 8.46, and therefore, LysM binds DNA with a relative high sequence specificity. This specificity is restricted to the half sites, particularly to positions −3 and −4, which are highly discriminative for a G-C and a C-G bp, respectively. The remainder of the sequence specificity in major groove recognition is largely contributed by position −7, displaying a preference for a G-C bp. As information content of individual positions is higher in half sites than in the central region, our analysis confirms recognition of two major groove segments and the intervening minor groove ([Figure 4](#gkt021-F4){ref-type="fig"}B). These results of the high-resolution contact mapping of the *lysW* operator are fully compatible with these data ([Figure 2](#gkt021-F2){ref-type="fig"}F). Unexpectedly, there is no pronounced preference for weak bps at central positions. Generally, the contribution of the minor groove-recognized part of a site to sequence preference is low and mostly arising from a preference for A-T or T-A bps, which facilitate minor groove compression. Most likely, this situation reflects the relative modest LysM-induced DNA bending. This is further confirmed by the observation that LysM~Sa~ binds mutant operators bearing an I-C at positions −1 and +1 with only a 1.3-fold higher affinity than mutant operators with G-C substitutions at both positions ([Supplementary Figure S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Inosine is identical to guanine in the major groove but lacks the exocyclic amino group that causes a steric hindrance for minor groove compression. Figure 4.Systematic bp substitution of the LysM consensus sequence to analyse sequence specificity of binding. In this figure, a representative example of such a binding analysis is shown for position −4, but analogous EMSAs have been performed and analysed for the other positions ([Supplementary Table S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). (**A**) EMSAs of LysM binding to variants harbouring a single-bp substitution at position −4. The bp change is mentioned on top of each autoradiograph, as are LysM~Sa~ concentrations (in nM). DNA fragments were prepared by hybridizing complementary oligonucleotides. (**B**) Graphical representation of the systematic bp substitution experiment in an energy-normalized sequence logo. The height of the stack of letters corresponds to the information content (bits).

Genome-wide *in vivo* mapping of LysM~Ss~ binding sites in *S. solfataricus*
----------------------------------------------------------------------------

LysM binding sites were identified on a genome-wide scale *in vivo*, using ChIP-chip assays with *S. solfataricus* cells grown in either presence or absence of exogenous lysine (5 mM) ([Figure 5](#gkt021-F5){ref-type="fig"}). Utilization of a LysM-specific nanobody for immunoprecipitation avoided the need of overexpressing or epitope-tagging LysM~Ss~.In total, 73 genomic regions distributed throughout the genome exhibited an enrichment of more than 4-fold (normalized log~2~ value of 2.0) in either both or one of the growth conditions. For several peaks, this enrichment even exceeded 8-fold. Resulting comprehensive dataset, obtained by setting the threshold at a log~2~ value of 2.0, is given in [Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1). Figure 5.Genome-wide distribution of LysM~Ss~ binding sites that are bound *in vivo*. (**A**) LysM~Ss~ binding profile across the *S. solfataricus* chromosome in cells in exponential growth phase grown in medium with supplementation of 5 mM lysine. The enrichment fold-ratio corresponds to the log~2~ of the signal ratio of ChIP-enriched DNA versus input DNA. Signals arising from biological duplicates are depicted in different colours (red/blue). Selected targets that are called in this growth condition (signals exceeding a log2 value of 2.0 in both biological duplicates), and for which binding is further analysed in this work, are labelled. (**B**) LysM~Ss~ binding profile across the *S. solfataricus* chromosome in cells grown in medium without additional supplementation of lysine. Notations are the same as in subpanel (A). (**C**) Pie chart showing the percentage of LysM binding sites associated with genes divided in functional categories.

These ChIP-chip assays provide first direct evidence of LysM~Ss~ being bound *in vivo* to the *lysW* operator ([Supplementary Figure S4](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Peak maxima were centred around the characterized binding motif. By applying qPCR to ChIP samples, we quantified enrichment of the *lysW* operator/promoter region as being ∼586- and 83-fold in absence and presence of lysine, respectively ([Supplementary Figure S5](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Significant binding was also detected at the *lysYZM* promoter region ([Supplementary Figure S4](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)), which was previously shown not to be bound by LysM *in vitro*. This observation necessitates revision of the statement that LysM~Ss~ is not involved in autoregulation and in regulation of *lysY* and *lysZ* ([@gkt021-B22]). However, it remains unclear whether LysM~Ss~ is associated at the *lysY* promoter because of direct recognition of a binding motif, or rather indirectly through protein--protein interactions (see later in the text).

Besides *lysW* and *lysY*, 71 previously unknown LysM~Ss~ targets were identified. Sequences of these ChIP-enriched regions were scanned with previously developed binding energy-based position weight matrix to predict the most probable binding motif ([Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). A comparison with the annotated genome information of *S. solfataricus* ([@gkt021-B40]) indicates that 76% of all predicted binding motifs are located in ORFs. Given a genome coding density of 84%, this percentage indicates only a slight over-representation of binding motifs being present in intergenic regions, which is unexpected for a specific transcription factor.

Positions of predicted motifs located in intergenic regions with respect to the closest translational start varied significantly, but many are located between 40 and 70 bp upstream of an initiation codon ([Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). There are also several cases in which, as for the *lysW* operator, the predicted motif is located at the 3′-end of an ORF and close to the promoter of a downstream gene or operon (see later, [Figure 6](#gkt021-F6){ref-type="fig"}A and F). Transcription units, of which expression is potentially influenced by LysM~Ss~, encode proteins with various functions, which can be classified in following categories: amino acid metabolism, central metabolism, transport, clustered regularly interspaced short palindromic repeats (CRISPR) immunity system, translation and hypothetical proteins For a distribution over the different functional categories, see [Figure 5](#gkt021-F5){ref-type="fig"} and [Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1). Curiously, LysM~Ss~ is associated with several tRNA genes and CRISPR loci. Furthermore, of particular interest are potential target genes that function in biosynthesis and transport of amino acids other than lysine, some of which are studied in more detail later in the text. Figure 6.*In vivo* and *in vitro* LysM~Ss~ binding for a selection of called ChIP-enriched regions: Sso0571 (**A**), *gltB* (**B**), *leuA*-2 (**C**), Sso1906 (**D**), Sso2043 (**E**), Sso2336 (**F**), Sso2497 (**G**) and Sso2824 (**H**). Zoomed profiles are plotted as the log~2~ of enrichment fold (y-axis) versus genomic position (*x*-axis). Signals arising from biological replicates are depicted in different colours, of which the code is provided in the figure inset in subpanel (A). Aligned with genomic positions, a schematic overview is given of intergenic and ORF regions. ORFs are depicted by open arrows and labelled. Intergenic regions are represented by a horizontal line. In each ChIP-enriched region, a red rectangle indicates the 15-bp sequence that is predicted to show the highest similarity to an LysM-binding motif. Below each binding profile, an EMSA is shown probing a fragment spanning the part of the ChIP-enriched region containing the predicted motif, which is indicated by a blue line \[in subpanel (F), two fragments are tested called 1 and 2\]. LysM~Ss~ concentrations are mentioned on top of the autoradiograph. Positions of free DNA (F), free single-stranded DNA (SS) and protein--DNA complexes (B1--B3) are indicated.

*In vitro* DNA-binding affinity of LysM~Ss~ for the *lysW* operator decreases on addition of lysine ([@gkt021-B22]). However, the *in vivo* LysM~Ss~ DNA-binding profiles appeared similar in either presence or absence of [l]{.smallcaps}-lysine ([Figure 5](#gkt021-F5){ref-type="fig"}).Based on the main criteria used for peak calling, namely, that peaks exceed a log~2~ value of 2.0 in both biological duplicates, not all peaks were called in both growth conditions. Nevertheless, for all peaks called in one condition, signals exceeded a log~2~ threshold of 1.0 in the other condition, indicating that there is no significant difference in binding profile in cells grown with and without exogenous lysine ([Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). However, it should be taken into account that ChIP-chip profiles do not provide a quantitative measure of DNA binding, as demonstrated for *lysW*: whereas ChIP profiles in both conditions appear similar ([Supplementary Figure S4](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)), qPCR quantification, which is more accurate because of a higher dynamic range, demonstrates a difference in enrichment of \>4-fold ([Supplementary Figure S5](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Consequently, despite the observation that ChIP binding profiles are similar on growth in presence and absence of lysine, DNA-binding characteristics such as affinity or stoichiometry might nevertheless be different.

Validation of ChIP-chip data with *in vitro* DNA-binding assays
---------------------------------------------------------------

*In vitro* DNA binding was analysed with EMSA for a selected subset of eight potential targets with varying predicted binding affinities and for which predicted binding motifs are located either in intergenic control regions or in ORFs ([Figure 6](#gkt021-F6){ref-type="fig"} and [Table 1](#gkt021-T1){ref-type="table"}). In this selection, we included targeted genes that are involved in amino acid metabolism: Sso0684 encodes a glutamate synthase (*gltB*), Sso0977 a 2-isopropylmalate synthase (*leuA-2*) and Sso1906 and Sso2043 both encode amino acid transporter-related proteins. We also included the control region of Sso0572 that codes for a conserved hypothetical ATPase of the PiLT family, for which predicted binding motif is located inside the preceding ORF, and of Sso2824, which encodes a formate dehydrogenase alpha subunit (*fdhF-2*). Two targets for which LysM~Ss~ binds into a coding region were also tested: these genes code for a hypothetical protein (Sso2336) and acyl-CoA dehydrogenase (Sso2497).

With exception of Sso2336, predicted binding motifs are located close to peak maxima ([Figure 6](#gkt021-F6){ref-type="fig"}). In EMSAs using 100- to 200-bp fragments comprising a sequence centred around the predicted motif, LysM~Ss~ binds with high affinity to control region fragments of *gltB*, *leuA-2* and Sso2043 ([Figure 6](#gkt021-F6){ref-type="fig"}B, C and E). Binding of LysM~Ss~ to *gltB* and *leuA*-2 resulted in concentration-dependent formation of two complexes, whereas three complexes were formed with Sso2043. Furthermore, low-affinity binding yielded two complexes for Sso1906 and Sso0572 and a single complex for the Sso2497 ORF fragment ([Figure 6](#gkt021-F6){ref-type="fig"}A, D and G). The other two targets (Sso2336 and Sso2824) formed either unstable complexes resulting in a smearing in EMSA or showed no complex formation ([Figure 6](#gkt021-F6){ref-type="fig"}F and H). In the former case, we also tested binding to a fragment-bearing part of the ORF of Sso2334 that corresponds better to the peak maximum of the cher, but again only weak binding resulting in some smearing at the highest protein concentrations was observed ([Figure 6](#gkt021-F6){ref-type="fig"}F).

We performed OP--Cu footprinting experiments for four fragments that exhibited high-affinity binding ([Figure 7](#gkt021-F7){ref-type="fig"}). For binding to *gltB* and *leuA*-2 operator fragments and to the Sso2497 ORF fragment, only a single protein--DNA complex was analysed ([Figure 7](#gkt021-F7){ref-type="fig"}A, B and D). In case of *gltB* and *leuA*-2, this complex corresponds to the fastest migrating complex B1 ([Figure 6](#gkt021-F6){ref-type="fig"}B and C). Without exception, the zone of protection is confirmed to contain the predicted LysM binding motif ([Figure 7](#gkt021-F7){ref-type="fig"}E). Figure 7.*In vitro* DNA-binding analysis for newly discovered LysM~Ss~ targets. (**A**) In-gel Cu--OP footprinting experiment of LysM~Ss~ binding to the control region of *gltB*. The autoradiograph of the EMSA is shown on top of the figure subpanel, with indication of LysM~Ss~ concentrations (in nM), position of single-stranded DNA (SS) and of excised DNA populations (I = input DNA, F = free DNA and B = bound DNA; indicated with rectangles). The autoradiograph of the denaturing gel is shown below the EMSA: A +G and C + T stand for the Maxam--Gilbert sequencing ladders, and I, B and F represent DNA populations. The protected region is indicated with a bar at the right side of the footprint autoradiograph. (**B**) In-gel Cu--OP footprinting experiment of LysM~Ss~ binding to the control region of *leuA-2*. Notations are the same as in subpanel (A). (**C**) In-gel Cu--OP footprinting experiment of LysM~Ss~ binding to the control region of Sso2043. Notations are the same as in subpanel (A), but in this case, there are three different bound DNA populations: B1, B2 and B3. Hyper-reactivity is indicated by a ball-and-stick symbol on the left side of the autoradiograph. (**D**) In-gel Cu--OP footprinting experiment of LysM~Ss~ binding to the ORF of Sso2497. Notations are the same as in subpanel (A). (**E**) Sequences of probed regions, with indication of protected regions (grey shade), 15-bp binding motifs (boxed) and position of hyper-reactivity effect (ball-and-stick symbol). For the three control regions, the sequences are aligned according to the translational start (with indication of the positions on top). The transcription start site is indicated with an arrow. For the Sso2497 ORF sequence, positions are indicated on top of the sequence.

Further analysis of three protein--DNA complexes formed with the Sso2043 control region indicated that in complex B1, which exhibits the highest relative mobility and is formed at lower protein concentrations than the two other complexes, the predicted binding motif is bound ([Figure 7](#gkt021-F7){ref-type="fig"}C and E). This finding confirms the high-affinity nature of this site (predicted K~D~ = 0.3 nM), which is rationalized by full conservation of all specificity-determining residues ([Table 1](#gkt021-T1){ref-type="table"}). In complex B2, which migrates with a lower relative mobility, footprinting indicates that LysM~Ss~ protects a different, but similarly sized, region. This region is located upstream of the high-affinity site and contains a binding motif with only one good half-site ([Figure 7](#gkt021-F7){ref-type="fig"}E). As centres of these two sites are 25 bp apart, they are contacted by the protein on opposite faces of the DNA helix. In complex B3, both sites are protected.

A ranking of all *in vitro* tested binding sites according to their *in silico* predicted K~D~ values results in a clustering of sites that are efficiently bound both *in vitro* and *in vivo* on the one hand (K~D~ \< 54 nM) and sites that are only bound *in vivo* on the other hand (K~D~ \> 78 nM) ([Table 1](#gkt021-T1){ref-type="table"}). The two categories of binding sites can be found in intergenic regions as well as in ORFs, and ∼24% of all binding regions contain a binding motif with a predicted K~D~ \<50 nM, indicating the presence of a true high-affinity LysM binding site ([Supplementary Dataset S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)). Binding at low-affinity sites might be stabilized *in vivo* on interaction with other sequence-specific DNA-binding or with nucleoid-associated proteins.

*In vivo* repression of LysM target genes by [l]{.smallcaps}-lysine supplementation
-----------------------------------------------------------------------------------

We measured the effect of [l]{.smallcaps}-lysine supplementation (5 mM) to growth medium on expression of *lysX* (second gene of *lysWXJK* operon), *leuA-*2, *gltB* and Sso1906 in wild-type cells with qRT-PCR ([Figure 8](#gkt021-F8){ref-type="fig"}). Addition of [l]{.smallcaps}-lysine results in a significant downregulation of all four LysM target genes tested, with the effect being most pronounced for *leuA-2* (10-fold reduction). Therefore, the expression of genes involved in biosynthesis, and possibly also transport, of other amino acids than lysine is significantly modulated in response to changes in intracellular lysine concentration. Figure 8.Relative gene expression analysis for LysM~Ss~ target genes *lysX*, *gltB*, *leuA*-2 and Sso1906 with qRT-PCR. Relative expression level is given as fold change of the expression level during growth in Brock medium with sucrose and 5 mM lysine versus the expression level during growth in Brock medium with sucrose lacking amino acids. Standard deviations (calculated for two biological replicates) are indicated.

Although differential expression of these genes in presence or absence of lysine is no conclusive proof for LysM~Ss~ regulation, it is likely that at least part of this regulatory response is direct and mediated by LysM~Ss~. This hypothesis is supported by the observation that binding characteristics are influenced by lysine concentration. as demonstrated by decreasing ChIP enrichment levels and binding affinities for the *lysW* operator at increasing lysine concentrations *in vivo* and *in vitro*, respectively ([Supplementary Figure S5](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt021/-/DC1)) ([@gkt021-B22]). In conclusion, it appears that LysM~Ss~ stimulates expression of all target genes at low intracellular lysine concentration.

Cofactor specificity of LysM
----------------------------

A systematic EMSA analysis of LysM~Ss~ binding to the *gltB* operator with all 20 naturally occurring [l]{.smallcaps}-amino acids as potential effector molecules confirmed that lysine reduces, but does not completely abolish, binding of LysM~Ss~, as observed previously for the *lysW* operator ([@gkt021-B22]) ([Figure 9](#gkt021-F9){ref-type="fig"}A and B). Furthermore, arginine, glutamine, isoleucine, leucine, methionine and valine also specifically reduce LysM binding at 5 mM. Similar results were obtained with *lysW*, *leuA*-2 and Sso2043 operator regions (data not shown). Similar as for lysine, addition of these six amino acids reduced binding affinity but did not completely abolish complex formation ([Figure 9](#gkt021-F9){ref-type="fig"}B). [l]{.smallcaps}-lysine has the strongest inhibitory effect of all tested potential effector molecules and therefore likely the highest affinity for LysM~Ss~ ([Figure 9](#gkt021-F9){ref-type="fig"}). It was found to exert a rather similar effect from ∼10 µM up to 5 mM, the highest concentration tested ([Figure 9](#gkt021-F9){ref-type="fig"}B and D). Figure 9.Effect of different cofactors on LysM~Ss~ DNA binding to the *gltB* control region on a 167-bp fragment monitored by EMSAs. (**A**) EMSAs to test binding in presence of each of the 20 [l]{.smallcaps}-amino acids. Positions of free DNA (F), single-stranded DNA (SS) and LysM~Ss~--DNA complexes (B1 and B2) are pointed out. In the bottom row above the autoradiograph, presence or absence of LysM~Ss~ in the reaction mixture is indicated as + or −, respectively. Used protein concentration is 250 nM. In the top row above the autoradiograph, the three-letter code of the added amino acid is displayed (final concentration 5 mM). (**B**) EMSAs in which a concentration gradient of a selection of amino acids was tested. Notations are similar as in subpanel A; amino acid concentrations are given in mM. (**C**) EMSAs to test the effect of the following molecules: [d]{.smallcaps}-lys = [d]{.smallcaps}-lysine; [l]{.smallcaps}-lys = [l]{.smallcaps}-lysine; [l]{.smallcaps}-gln = [l]{.smallcaps}-glutamine; 2-OG = 2-oxoglutarate; DAP = D,[l]{.smallcaps}-α,ε-diaminopimelic acid; [l]{.smallcaps}-arg = [l]{.smallcaps}-arginine; [l]{.smallcaps}-can = [l]{.smallcaps}-canavanine; [l]{.smallcaps}-homoarg = [l]{.smallcaps}-homoarginine; [l]{.smallcaps}-cit = [l]{.smallcaps}-citrulline; [l]{.smallcaps}-orn = [l]{.smallcaps}-ornithine. Notations are similar as in subpanel (A and B). All cofactor concentrations are displayed in mM. For binding reactions to which [l]{.smallcaps}-glutamine and two-oxoglutarate are added simultaneously (indicated by '[l]{.smallcaps}-gln + 2-OG'), shown concentrations correspond to [l]{.smallcaps}-glutamine, whereas 2-oxoglutarate had a final concentration of 5.0 mM in both binding reactions. (**D**) EMSAs to test low concentration gradients for a selection of cofactors. Notations are similar as in subpanel (A, B and C). However, in this subpanel, cofactor concentrations are displayed in μM. (**E**) Molecular structures of LysM effector molecules (except for branched-chain amino acids) tentatively ranked according to the strength of their inhibitory effect. The shaded atom in the [l]{.smallcaps}-lysine and [d]{.smallcaps}-lysine structure indicates a stereochemical difference at this position.

We tested a series of precursors of lysine, arginine and glutamine biosynthesis or analogues of lysine and arginine that show structural similarities with lysine ([Figure 9](#gkt021-F9){ref-type="fig"}C and E). The EMSA experiments indicate that [d]{.smallcaps}-lysine and [l]{.smallcaps}-homoarginine also exert a negative effect on LysM~Ss~ binding, even in µM range ([Figure 9](#gkt021-F9){ref-type="fig"}D), and that homoarginine is a more potent cofactor than arginine. The effect of [l]{.smallcaps}-canavanine and [l]{.smallcaps}-citrulline was less pronounced, whereas [l]{.smallcaps}-ornithine and D,[l]{.smallcaps}-α,ε-diaminopimelic acid had no significant effect ([Figure 9](#gkt021-F9){ref-type="fig"}C). Similarly, 2-oxoglutarate had no effect by itself and neither did it interfere with the negative effect of glutamine ([Figure 9](#gkt021-F9){ref-type="fig"}C).

Combined, these results indicate that both the amino group of [l]{.smallcaps}- and [d]{.smallcaps}-lysine and the guanidino group of arginine and homoarginine can be accommodated in the cofactor binding-pocket. The optimal length of the cofactor side chain is four CH~2~-groups.

DISCUSSION
==========

Lrp-like regulators are abundantly present in archaeal genomes ([@gkt021-B3]) and appear to play an important role in adaptation of cellular metabolism to variations in concentration of amino acids as signaling molecules ([@gkt021-B2],[@gkt021-B41],[@gkt021-B42]). Some bacterial or archaeal Lrps control only a single or a few target genes, whereas others regulate a vast number of genes involved in various pathways ([@gkt021-B1],[@gkt021-B42],[@gkt021-B43]). Here we identify 73 binding sites for LysM and demonstrate that LysM is a much more versatile regulator than originally thought. Binding sites for LysM may occur singly or in combination with an auxiliary more degenerated LysM box, as demonstrated for *lysW* and *Sso2043*. LysM is not only involved in transcriptional control of lysine biosynthesis, but it also modulates expression of genes involved in biosynthesis of leucine and glutamate and of genes annotated as amino acid transport-related. Clearly, the control of amino acid metabolism and transport is a primary task of LysM, although the transcription factor also binds in the neighbourhood of promoters expressing genes with a variety of other functions.

Lysine is the main effector molecule of LysM. *In vitro* DNA binding was invariably reduced in the presence of lysine and *in vivo*, a significant downregulation was observed on lysine supplementation for all four tested targets (*lysX*, *gltB*, *leuA-*2 and Sso1906). We can assume that this regulatory response originates at least partially from LysM action, and it is strongly suggested that LysM functions as an activator. Although FL11 from *Pyrococcus sp.* OT3 and LysM have similar cofactor specificity with lysine as the major coregulator, their mode of action is clearly different. Whereas FL11 generally works as a repressor of which the activity is relieved in presence of lysine ([@gkt021-B9]), LysM appears to act as a transcriptional activator in absence of lysine. For *lysW*, *leuA*-2, Sso1906 and Sso2043, the main LysM binding site is located just upstream of predicted BRE and TATA box elements ([Figure 7](#gkt021-F7){ref-type="fig"}E). This is reminiscent of activation by Ptr2, an Lrp-like transcription factor from *M. jannaschii* that binds at an equivalent relative position and activates transcription by stimulating protein--protein interactions with TBP ([@gkt021-B20]). In the cases of *Sso2043* and *lysW*, binding of LysM at a secondary accessory binding site located either upstream or downstream of the core binding site ([Figures 2](#gkt021-F2){ref-type="fig"}F and [7](#gkt021-F7){ref-type="fig"}E) might contribute to more profound regulatory effects: either further activation or a switch to repression. In contrast, the distance between the main LysM binding site and the translational initiation site in the *gltB* promoter region suggests that the regulator is positioned in between the promoter region and initiation site.

Often, Lrp-like regulators display a cofactor promiscuity ([@gkt021-B9],[@gkt021-B17],[@gkt021-B44]). Here we demonstrate that, besides lysine, several other amino acids (i.e. arginine, glutamine, leucine, isoleucine, methionine and valine) reduce DNA-binding affinity of LysM ([Figure 9](#gkt021-F9){ref-type="fig"}). The preference for the most potent effector molecules, that is lysine \> arginine \> glutamine, is identical as for FL11, and the structural basis for this similarity lies in conservation of a glutamine at position 97 and an aspartate at position 121. Side-chain oxygen molecules of these residues form hydrogen bonds with the lysine side chain, thereby determining ligand specificity ([@gkt021-B45]). An arginine-FL11 cocrystal structure demonstrates that arginine is less efficient because of the longer side chain causing conformational changes in the protein ([@gkt021-B45]), and we can assume that a similar situation occurs in LysM. The stronger effect of homoarginine observed for LysM can be explained by its larger structural similarity to lysine (4 CH~2~-groups preceding an N-atom that may engage in H-bonding) ([Figure 9](#gkt021-F9){ref-type="fig"}E). Competitive binding of different amino acids, each with a different affinity, will allow an adapted regulatory response to the nutritional state of the cell. This state is reflected by concentration ratios of different amino acids rather than by the absolute concentration of a single amino acid type. Furthermore, a broad cofactor specificity is also rationalized by the observation that LysM regulates not only lysine biosynthesis but also biosynthesis and transport of other amino acids.

All LysM~Ss~ targets were bound *in vivo* in growth conditions with and without lysine supplementation, whereas enrichments quantified by qPCR, *in vitro* binding affinity of LysM and promoter activities were invariably lower in the presence of lysine. This indicates that ChIP-chip is not a valid quantitative measure of target site occupancy and likely reflects the observation that lysine reduces, but does not completely abolish, binding of LysM, an observation that was made with all six tested intergenic and intragenic binding sites (*lysW*, *gltB*, *leuA*-2, Sso1906, Sso2043 and Sso2497, [Figure 9](#gkt021-F9){ref-type="fig"} and data not shown). It is also reminiscent of the effect of [l]{.smallcaps}-leucine on DNA-binding capacity of *E. coli* Lrp ([@gkt021-B46],[@gkt021-B47]), although in this case, ChIP-chip DNA-binding profiles were clearly sensitive to the presence of exogenous leucine ([@gkt021-B16]). The mechanisms underlying the negative effect of ligand binding on DNA-binding affinity of LysM are not yet understood. In some instances, such as for *E. coli* Lrp and the archaeal FL11, cofactor binding influences the association state of the Lrp-like protein, thereby shifting the equilibrium between different oligomeric forms that each have different DNA-binding characteristics ([@gkt021-B45],[@gkt021-B48]). However, this is not a general rule and ligand binding might also induce more subtle conformational changes ([@gkt021-B6],[@gkt021-B8]). Preliminary data indicate that this is the case for LysM, as lysine does not affect the tetrameric state of the regulator in solution ([@gkt021-B22]). Possibly, effector binding reduces the DNA-binding capacity of LysM by re-orienting two helix-turn-helix motifs with respect to successive major groove segments of the operator. Besides diminishing DNA-binding affinity, this re-orientation could equally modify the position of the C-terminal surface responsible for transcription regulation with respect to elements of the basal transcription apparatus, thereby affecting regulatory outcome.

LysM does not appear to control expression of other transcription factors. Nevertheless, it cannot be excluded that LysM is involved in regulatory networking. This situation might occur at targets that are efficiently bound *in vivo* but not *in vitro*, as demonstrated for Sso2824 and Sso2334-2336. Such differential binding is generally ascribed to involvement of co-regulators, other transcription factors or nucleoid-associated proteins, which may enhance binding affinity and/or stability at sites with a low intrinsic affinity for the regulator. In a proteome-wide study of protein--protein interactions in *Pyrococcus horikoshii* OT3, hetero-interactions have been identified for two Lrp-like proteins ([@gkt021-B49]). Additionally, FL9 and DM1 from *Pyrococcus* OT3, a full-length and truncated Lrp protein, respectively, have been shown to form hetero-octamers ([@gkt021-B44]). Possibly, LysM is capable of establishing such hetero-oligomeric interactions, thereby largely expanding its regulatory power, both with respect to effector response as to target gene repertoire. Whether LysM exerts autoregulation is not entirely clear. *In vivo*, LysM associates with the *lysYZM* promoter region, but we did not detect binding *in vitro*, and northern blotting indicated that production of *lysY* and *lysM* mRNA was not affected on addition of lysine ([@gkt021-B22]).

A large fraction (76%) of LysM-binding sites is located inside translated regions. Eleven of these are predicted to harbour a high-affinity *bona fide* LysM-binding motif (theoretical K~D~ \< 50 nM). Such a high frequency of intragenic binding sites is unusual for bacterial transcriptional regulators ([@gkt021-B16],[@gkt021-B50; @gkt021-B51; @gkt021-B52]), with *E. coli* RutR as an exception ([@gkt021-B53]). For archaeal transcription factor TrmB of *Halobacterium salinarum NRC-*1, 40% of binding sites are located inside coding sequences ([@gkt021-B54]). Possibly, intragenic binding is more common for archaeal than for bacterial transcription factors, given their more compact genome organizations and smaller average intergenic region lengths ([@gkt021-B55]). Indeed, some LysM~Ss~ targets, for example the *lysW* and Sso0572 operators, appear to be true promoter-associated regulatory sites while located in the 3′-end of the preceding ORF sequence. Other intragenic sites might also have regulatory functions for as yet undetected transcription units, given the flexible transcriptome architecture of *S. solfataricus* with a high abundance of conditionally active initiation and termination sites inside operons and of small RNAs ([@gkt021-B56],[@gkt021-B57]). Alternatively, these binding sites do not function in direct transcription regulation but serve to control the intracellular concentration of free regulatory protein, or they merely occur by chance without any functionality and have not been removed by evolution, as was postulated for RutR ([@gkt021-B53]).

LysM~Ss~ is associated with both control regions of genes encoding amino acid transporters (Sso1906/Sso2043) in paralogous highly conserved gene clusters that also contain a glutamate dehydrogenase located downstream of the transporter gene and a divergently transcribed allantoin permease. The Sso1906 gene cluster is flanked by a transposase, suggesting that gene duplication was mediated by a transposition event ([@gkt021-B58]). The intergenic regions are highly conserved without a selective pressure for conservation of the LysM-binding motifs (data not shown). *In vitro*, LysM~Ss~ binds with a significantly higher affinity to the promoter region of the ancestral Sso2043, which contains a binding motif corresponding perfectly to the consensus sequence, than to the Sso1906 promoter, in which two mismatches have originated at specificity-determining positions ([Figure 6](#gkt021-F6){ref-type="fig"} and [Table 1](#gkt021-T1){ref-type="table"}). Moreover, the accessory binding site identified in the Sso2043 control region is lost in the Sso1906 control region. Therefore, although our ChIP-chip data indicate that this LysM~Ss~ regulatory interaction has been inherited after the gene duplication event, differences in binding affinity might lead to differential regulation. As a consequence, the duplicated genes might respond slightly different to metabolic needs, thereby placing a selection pressure on maintenance of the duplicated gene cluster and on further degeneration and possibly even on the future loss of the LysM~Ss~-binding motif in the Sso1906 promoter region. Our analysis has provided a 'snapshot' of the evolutionary expansion of the LysM~Ss~ regulon.

This work illustrates the power of genome-wide ChIP approaches to obtain a global view of the full-range target site distribution of a transcription factor, but also stresses the necessity to couple such techniques to in-depth studies for a correct interpretation and full understanding of the physiological role of the regulator in the cell.
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[^1]: Binding motifs are ranked according to their predicted K~D~s, and it is indicated to what extent these targets are bound *in vitro*: (−) no binding; (+) low-affinity binding \[either unstable binding (smearing) or not all free DNA is complexed at high LysM concentrations\]; (++) high-affinity binding (all free DNA is complexed at intermediate LysM concentrations). Predicted motifs are given with indication of conservation of specificity-determining residues (bold). We refer to [Figures 1](#gkt021-F1){ref-type="fig"} and [6](#gkt021-F6){ref-type="fig"} for the corresponding EMSA images.
